Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT02938260
Eligibility Criteria:
Inclusion Criteria:
* Non-pregnant adults ≥18 years of age with AF RVR (HR \>120 bpm), which will be obtained from vital signs or electrocardiogram, in the emergency department, who have an EF \<40% from an echocardiogram within the previous 4 years, and are treated with IV push metoprolol or diltiazem as first line for rate control of AF with RVR. Patients can receive up to two IV push doses but cannot switch treatment medication between these two doses.
Exclusion Criteria:
* Patients with a SBP \<90 mmHg or decompensated heart failure (ie those presenting primarily with worsening of heart failure signs and symptoms, including dyspnea and lower extremity edema). Patients who are admitted multiple times within the time frame or have multiple episodes will be excluded except for the first episode within the first admission.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02938260
Study Brief:
Protocol Section:
NCT02938260